For Healthcare Professionals: Kidney Cancer: Related News

On Our Blog

Pictured: Robert J. Motzer
Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option

An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.

August 22, 2013
Pictured: Pramod Sogani
Pramod Sogani Inaugurated As President of the American Urological Association

Memorial Sloan Kettering urologic surgeon Pramod Sogani has been inaugurated as President of the American Urological Association. In this Q&A he discusses his goals and his new role.

July 1, 2013
Pictured: Paul Russo
Many Affected by Kidney Cancer Are Not Informed about Kidney-Sparing Surgery Option

A study has found that the majority of kidney cancer patients with small tumors have their entire kidney removed, which can increase the risk of developing chronic kidney disease and cardiovascular complications.

May 20, 2013
Pictured: Robert Motzer & Suzanne Gornell
Physicians and Scientists at Memorial Sloan Kettering Pioneer the Development of Kidney Cancer Treatments

Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

May 8, 2013